Wednesday, September 4, 2013

Patent ruling on Lilly's Alimta lung-cancer drug expected in 2014

(Reuters) - A high-stakes decision on whether to extend U.S. marketing exclusivity of Eli Lilly and Co's blockbuster Alimta lung cancer drug is not expected until next year, following a two-week trial in Indianapolis federal court.

No comments:

Post a Comment

Subscribe Now: Feed Icon